SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024194
Filing Date
2022-11-10
Accepted
2022-11-10 08:31:12
Documents
47
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q labp-20220930.htm   iXBRL 10-Q 2026858
2 EX-31.1 labp-ex31_1.htm EX-31.1 28361
3 EX-32.1 labp-ex32_1.htm EX-32.1 17283
  Complete submission text file 0000950170-22-024194.txt   6409034

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT labp-20220930.xsd EX-101.SCH 33393
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT labp-20220930_def.xml EX-101.DEF 123691
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT labp-20220930_cal.xml EX-101.CAL 33790
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT labp-20220930_lab.xml EX-101.LAB 331747
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT labp-20220930_pre.xml EX-101.PRE 231055
41 EXTRACTED XBRL INSTANCE DOCUMENT labp-20220930_htm.xml XML 1128999
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39971 | Film No.: 221375118
SIC: 2834 Pharmaceutical Preparations